Hypoxia and acidosis are common features of several physiological and pathological situations, including cancer and stroke. The HIF (hypoxia-inducible factor) transcription factor plays a seminal role in orchestrating cellular responses to alterations in oxygen availability. HIF is degraded in normal oxygen tension by the VHL (von Hippel-Lindau) tumor suppressor protein but stabilized by hypoxia to activate an array of genes implicated in oxygen homeostasis including vascular endothelial growth factor. Cells respond to a comparatively mild decline in oxygen tension by converting to an anaerobic state of respiration and secreting lactic acid. We recently reported that a decrease in environmental pH triggers sequestration of VHL into the nucleolus neutralizing its ability to degrade HIF. This implies that cells have evolved a parallel mechanism of HIF activation that responds to changes in oxygen levels by sensing extracellular [H+]. Here we discuss the implications of this new VHL regulatory mechanism on oxygen homeostasis and hypoxic cell memory.
Ischaemia occurs in cardiac arrest, stroke, muscle stress, cancer, and normal development. [1] [2] [3] [4] Within these physiological and pathological settings, the HIF (hypoxia-inducible factor) transcription factor activates genes implicated in cellular response to low oxygen availabilty. Among others, HIF induces genes that modulate angiogenesis, glycolysis, growth and pH regulation. [5] [6] [7] In the presence of oxygen, the α subunit of HIF (HIFα) is post-translationally modified at key proline residues by enzymes known as prolyl hydroxylases (PHDs) (Fig. 1A) . [8] [9] [10] [11] [12] This allows the VHL tumor suppressor, a component of an E3 ubiquitin ligase (Fig. 1A) , to recognize HIF and target it for degradation (refs. 8-24 and reviewed in ref. 25) . PHDs require molecular oxygen and hypoxia prevents hydroxylation of HIF. [8] [9] [10] [11] [12] 26, 27 This has led to the notion that PHDs act as "oxygen sensors" gauging oxygen tension and determining whether cells should engage in HIF activation.
Cells adapt to a decrease in oxygen tension by engaging in metabolic fermentation following an increase in the glycolytic rate. This results in acidification of the extracellular milieu due to excess production of lactic acid. Acidosis has been reported to be more than an innocent bystander in this process. In fact, low pH values exert protective effects under numerous physiological and pathological settings. [28] [29] [30] [31] [32] This led us to investigate the VHL-HIF system in hypoxic cells that are allowed to undertake the natural route to acidosis. 33 We found that hypoxia-induced acidosis triggered relocalization of VHL from a diffuse nuclear-cytoplasmic pattern to nucleoli (Fig. 1B) . 33 VHL remained confined to nucleoli upon reoxygenation but reverted to its original nuclear-cytoplasmic distribution when neutral pH conditions were reinstated. Nucleolar localization of VHL also occurred in normoxia following extracellular acidification by metabolically active cells (Warburg Effect) . 34, 35 Nucleolar sequestration of VHL stabilized HIF and activated its targets. Therefore, we reasoned that an increase in the levels of hydrogen ions might trigger nucleolar sequestration of VHL in hypoxia or normoxia to elicit a mechanistically reversible loss of VHL function followed by HIF activation.
We propose a model in which pH-dependent regulation of VHL intersects with the previously identified oxygen-dependent control of HIF. Acidosis is observed in ischaemic tissues and is a function of the hypoxic stress as defined by the severity and the duration of the decrease in oxygen concentration as well as the microenvironmental buffering capacity. Once achieved, acidosis triggers nucleolar confinement of VHL abolishing its ability to degrade HIF. Nucleolar sequestration-dependent inactivation of VHL is refractory to oxygen levels but not to the reinstatement of neutral extracellular pH. We thus speculate that prolonged HIF stabilization by acidosis-dependent nucleolar sequestration of VHL serves as a mechanism of hypoxic cell memory (Fig. 2 ) that enables cells to discount the effect of reoxygenation. Since acidosis is known to protect cells against several different toxic effects including anoxic cell killing and glucose starvation, [28] [29] [30] [31] [32] it is reasonable to suspect that cells would benefit from a hypoxic cell memory. In accordance with this concept, the levels of HIF and the products of its target genes remain elevated following ischaemia-reperfusion, and this is associated with several protective effects. 36, 37 A closer examination of our model (Fig. 2) identifies a central role for pH-dependent regulation of VHL function in oxygen sensing. Cells can engage in anaerobic fermentation and secrete lactic acid once oxygen concentration decreases by 50-70% of normal levels. 38 This argues that cells can sense mild hypoxia and produce sufficient H + to trigger HIF activation before PHD inactivation (Fig. 2) . 11, 12, 38 According to this model, a "respiratory enzyme" would act as the oxygen sensor and regulate HIF activation by directing cells towards the citric acid cycle or fermentation as originally postulated by Otto Heinrich Warburg. 34, 35 Disruption of the extracellular matrix is thought to facilitate tumor vascularization. In addition to causing unregulated HIF activation, loss of VHL function also disrupts fibronectin depostion. [39] [40] [41] [42] Therefore, inactivation of VHL by nucleolar sequestration may serve the dual role of preventing extracellular matrix assembly and promoting HIF activation in hypoxic-acidotic cells thereby crafting a highly favourable environment to stimulate angiogenesis. This is supported by mathematical models predicting a role for H + in tumor development, including disruption of the extracellular matrix. 43, 44 Nucleolar sequestration may also abolish uncharacterized VHL functions or even yet allow VHL to assume new duties within the nucleolus. It will be of outmost importance to test whether key VHL functions, in addition to its regulatory role in HIF activation, are affected by the localization of this tumor suppressor to the nucleolus.
Inactivating mutations within the VHL gene are associated with von Hippel-Lindau disease-a cancer syndrome predisposing individuals for the development of retinal angioma, central nervous system hemangioblastoma, pheochromocytoma and renal clear cell carcinoma (RCC). 25 Loss of HIF regulation by VHL is believed to play a role in cancers retaining wild-type VHL through inactivation of PHDs in hypoxic tumors. 5 Since acidosis is commonly observed within the core of tumors, it is conceivable that inactivation of VHL may occur by pH-dependent nucleolar sequestration. This would imply that VHL-expressing tumors are not under any selective pressure to acquire inactivating mutations within this gene since its product can be efficiently inactivated by acidosis. 
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In a 1999 Nature "News and Views", Jeffrey Bachant and Stephen Elledge hypothesized that the nucleolus can serve as an organelle by which cellular processes can be regulated through physical confinement of proteins. 45 Our data are consistent with this hypothesis and suggest a common pH-dependent regulatory mechanism of VHL function. This regulatory process is similar to that observed in another system in which the MDM2 E3 ubiquitin ligase is confined to nucleoli to prevent the degradation of p53 in response to physiological cues. [46] [47] [48] Therefore, the nucleolus is implicated in both the activation and inactivation of tumor suppressor proteins, depending on the stress signal. 33, [46] [47] [48] In conclusion, our recent study identifies nucleolar sequestration as a mechanism of inactivation of HIF destruction by VHL. Due to the abundance of evidence supporting the role of HIF in disease and normal physiology, alterations in pH, or mutations affecting the pH-responsiveness of VHL, may therefore have various important implications. The challenge will be to identify the role of nucleolar VHL within such physiological settings in vivo. Furthermore, it is possible that nucleolar sequestration of VHL might occur in response to signals other than acidosis, implying a more complex system of oxygen sensing than previously appreciated. Characterization of the exact mechanism of nucleolar localization might assist in the identification of such signals and could uncover novel therapeutic targets.
